Adenovirus-vectored drug–vaccine duo as a potential driver for conferring mass protection against infectious diseases

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Expert Review of Vaccines

• Publication date

  2011-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1586/erv.11.141PMID 22043954
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dissolving polymer microneedle patches for influenza vaccination

  2012cited by this paper
• Potential of nasopharynx-associated lymphoid tissue for vaccine responses in the airways.

  2011cited by this paper
• Inflammation‐related effects of adjuvant influenza A vaccination on platelet activation and cardiac autonomic function

  2011cited by this paper
• Inflammatory mechanisms in obesity.

  2011cited by this paper
• Recombinant Adenovirus Serotype 26 (Ad26) and Ad35 Vaccine Vectors Bypass Immunity to Ad5 and Protect Nonhuman Primates against Ebolavirus Challenge

  2011cited by this paper
• Avian Influenza Mucosal Vaccination in Chickens with Replication-Defective Recombinant Adenovirus Vaccine

  2011cited by this paper
• Creation of a panel of vectors based on ape adenovirus isolates

  2011cited by this paper
• Cross-Species Transmission of a Novel Adenovirus Associated with a Fulminant Pneumonia Outbreak in a New World Monkey Colony

  2011cited by this paper
• Live Attenuated Influenza Vaccine (FluMist®; Fluenz™)

  2011cited by this paper
• Adenovirus-Vectored Drug-Vaccine Duo as a Rapid-Response Tool for Conferring Seamless Protection against Influenza

  2011cited by this paper
• Systemic Delivery of a Novel Liver-Detargeted Oncolytic Adenovirus Causes Reduced Liver Toxicity but Maintains the Antitumor Response in a Breast Cancer Bone Metastasis Model

  2011cited by this paper
• International seroepidemiology of adenovirus serotypes 5, 26, 35, and 48 in pediatric and adult populations.

  2011cited by this paper
• Induction of Broadly Neutralizing H1N1 Influenza Antibodies by Vaccination

  2010cited by this paper
• Development and functional specialization of CD103+ dendritic cells

  2010cited by this paper
• Vector Choice Determines Immunogenicity and Potency of Genetic Vaccines against Angola Marburg Virus in Nonhuman Primates

  2010cited by this paper
• Dissolving Polymer Microneedle Patches for Influenza Vaccination

  2010cited by this paper
• Mucosal adenovirus-vectored vaccine for measles.

  2010cited by this paper
• Electroporation for DNA immunization: clinical application

  2010cited by this paper
• Protection of Nonhuman Primates against Two Species of Ebola Virus Infection with a Single Complex Adenovirus Vector

  2010cited by this paper
• Attenuation of inducible respiratory immune responses by oseltamivir treatment in mice infected with influenza A virus.

  2010cited by this paper
• Route of Adenovirus-Based HIV-1 Vaccine Delivery Impacts the Phenotype and Trafficking of Vaccine-Elicited CD8+ T Lymphocytes

  2010cited by this paper
• A Porcine Adenovirus with Low Human Seroprevalence Is a Promising Alternative Vaccine Vector to Human Adenovirus 5 in an H5N1 Virus Disease Model

  2010cited by this paper
• Generation of Mucosal Dendritic Cells from Bone Marrow Reveals a Critical Role of Retinoic Acid

  2010cited by this paper
• Long-Term Thermostabilization of Live Poxviral and Adenoviral Vaccine Vectors at Supraphysiological Temperatures in Carbohydrate Glass

  2010cited by this paper
• Genetic immunization in the lung induces potent local and systemic immune responses

  2010cited by this paper
• Induction of type I interferon by adenovirus-encoded small RNAs

  2010cited by this paper
• The role of inflammation in the pathogenesis of non-small cell lung cancer.

  2010cited by this paper
• Non-replicating adenovirus vectors expressing avian influenza virus hemagglutinin and nucleocapsid proteins induce chicken specific effector, memory and effector memory CD8(+) T lymphocytes.

  2010cited by this paper
• Prophylactic Administration of Bacterially Derived Immunomodulators Improves the Outcome of Influenza Virus Infection in a Murine Model

  2010cited by this paper
• In vivo function of Langerhans cells and dermal dendritic cells.

  2010cited by this paper
• Avian Influenza Vaccination in Chickens and Pigs with Replication-Competent Adenovirus–Free Human Recombinant Adenovirus 5

  2010cited by this paper
• Computational analysis of adenovirus serotype 5 (HAdV-C5) from an HAdV coinfection shows genome stability after 45 years of circulation.

  2010cited by this paper
• Enemy at the gates: dendritic cells and immunity to mucosal pathogens

  2010cited by this paper
• Protective Immunity Against a Lethal Respiratory Yersinia pestis Challenge Induced by V Antigen or the F1 Capsular Antigen Incorporated into Adenovirus Capsid

  2010cited by this paper
• Sublingual Administration of an Adenovirus Serotype 5 (Ad5)-Based Vaccine Confirms Toll-Like Receptor Agonist Activity in the Oral Cavity and Elicits Improved Mucosal and Systemic Cell-Mediated Responses against HIV Antigens despite Preexisting Ad5 Immunity

  2010cited by this paper
• Does an acute inflammatory response temporarily attenuate parasympathetic reactivation?

  2010cited by this paper
• Mitochondrial dysfunction: a potential link between neuroinflammation and neurodegeneration?

  2010cited by this paper
• Intranasal Mucosal Boosting with an Adenovirus-Vectored Vaccine Markedly Enhances the Protection of BCG-Primed Guinea Pigs against Pulmonary Tuberculosis

  2009cited by this paper
• Lymph Node Stromal Cells Support Dendritic Cell-Induced Gut-Homing of T Cells1

  2009cited by this paper
• Induction of mucosal immunity in the avian Harderian gland with a replication-deficient Ad5 vector expressing avian influenza H5 hemagglutinin.

  2009cited by this paper
• Adenovirus vector vaccination induces expansion of memory CD4 T cells with a mucosal homing phenotype that are readily susceptible to HIV-1

  2009cited by this paper
• Optimization of vaccine responses with an E1, E2b, E3 deleted Ad5 vector circumvents pre-existing anti-vector immunity

  2009cited by this paper
• Augmented Lung Inflammation Protects against Influenza A Pneumonia

  2009cited by this paper
• Influenza virus resistance to antiviral agents: a plea for rational use.

  2009cited by this paper
• DNA vaccination protects against an influenza challenge in a double-blind randomised placebo-controlled phase 1b clinical trial.

  2009cited by this paper
• Vaccine-derived poliovirus (VDPV): Impact on poliomyelitis eradication.

  2009cited by this paper
• P19-47. Novel adenovirus type 5 vaccine platform induces cellular immunity against HIV-1 Gag, Pol, Nef despite the presence of Ad5 immunity

  2009cited by this paper
• Adenovirus Vectors Expressing Hantavirus Proteins Protect Hamsters against Lethal Challenge with Andes Virus

  2009cited by this paper
• Adenovirus as a carrier for the development of influenza virus-free avian influenza vaccines

  2009cited by this paper
• An adenoviral vector-based mucosal vaccine is effective in protection against botulism

  2009cited by this paper
• Evaluation of two live attenuated cold-adapted H5N1 influenza virus vaccines in healthy adults.

  2009cited by this paper
• Protection of chickens against avian influenza with nonreplicating adenovirus-vectored vaccine.

  2009cited by this paper
• Comparative analysis of vector biodistribution, persistence and gene expression following intravenous delivery of bovine, porcine and human adenoviral vectors in a mouse model.

  2009cited by this paper
• Oral immunization of raccoons and skunks with a canine adenovirus recombinant rabies vaccine.

  2009cited by this paper
• Transient Facial Nerve Paralysis (Bell's Palsy) following Intranasal Delivery of a Genetically Detoxified Mutant of Escherichia coli Heat Labile Toxin

  2009cited by this paper
• Delivery of Human Immunodeficiency Virus Vaccine Vectors to the Intestine Induces Enhanced Mucosal Cellular Immunity

  2009cited by this paper
• A critical role for type I IFN-dependent NK cell activation in innate immune elimination of adenoviral vectors in vivo.

  2008cited by this paper
• Nasal Delivery of an Adenovirus-Based Vaccine Bypasses Pre-Existing Immunity to the Vaccine Carrier and Improves the Immune Response in Mice

  2008cited by this paper
• Protection of chickens against avian influenza with non-replicating adenovirus-vectored vaccine.

  2008cited by this paper
• Adenovirus vector induced innate immune responses: impact upon efficacy and toxicity in gene therapy and vaccine applications.

  2008cited by this paper
• Influenza-associated central nervous system dysfunction: a literature review.

  2008cited by this paper
• HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis.

  2008cited by this paper
• Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial.

  2008cited by this paper
• DNA vaccines: ready for prime time?

  2008cited by this paper
• Toward the development of vectored vaccines in compliance with evolutionary medicine

  2008cited by this paper
• Protective Immunity to Pseudomonas aeruginosa Induced with a Capsid-Modified Adenovirus Expressing P. aeruginosa OprF

  2007cited by this paper
• Automated mass immunization of poultry: the prospect for nonreplicating human adenovirus-vectored in ovo vaccines

  2007cited by this paper
• Comparison of adenoviruses from species B, C, E, and F after intravenous delivery.

  2007cited by this paper
• Protective avian influenza in ovo vaccination with non-replicating human adenovirus vector.

  2007cited by this paper
• In Vitro Induction of Mucosa-Type Dendritic Cells by All-Trans Retinoic Acid1

  2007cited by this paper
• Adenovirus-based prime-boost immunization for rapid vaccination against anthrax.

  2007cited by this paper
• TLR3 Deficiency in Patients with Herpes Simplex Encephalitis

  2007cited by this paper
• Pulmonary Immunity to Viral Infection: Adenovirus Infection of Lung Dendritic Cells Renders T Cells Nonresponsive to Interleukin-2

  2006cited by this paper
• Topical Application of Escherichia coli-Vectored Vaccine as a Simple Method for Eliciting Protective Immunity

  2006cited by this paper
• Protection of Mice and Poultry from Lethal H5N1 Avian Influenza Virus through Adenovirus-Based Immunization

  2006cited by this paper
• Protective Immunity against Respiratory Tract Challenge with Yersinia pestis in Mice Immunized with an Adenovirus-Based Vaccine Vector Expressing V Antigen

  2006cited by this paper
• FDA, Producers Moving toward Mammalian Cell-Based Flu Vaccines

  2006cited by this paper
• Development of adenoviral-vector-based pandemic influenza vaccine against antigenically distinct human H5N1 strains in mice.

  2006cited by this paper
• Complex effect of adenovirus early region proteins on innate immune system.

  2006cited by this paper
• A new intranasal influenza vaccine based on a novel polycationic lipid--ceramide carbamoyl-spermine (CCS) I. Immunogenicity and efficacy studies in mice.

  2006cited by this paper
• The US smallpox vaccination program: a review of a large modern era smallpox vaccination implementation program.

  2005cited by this paper
• Safety and immunogenicity of adenovirus-vectored nasal and epicutaneous influenza vaccines in humans.

  2005cited by this paper
• Professional Antigen-Presentation Function by Human γδ T Cells

  2005cited by this paper
• Professional antigen-presentation function by human gammadelta T Cells.

  2005cited by this paper
• Adenovirus-Based Genetic Vaccines for Biodefense

  2005cited by this paper
• Current Status of Gendicine in China: Recombinant Human Ad-p53 Agent for Treatment of Cancers

  2005cited by this paper
• Inflammatory Exposure and Historical Changes in Human Life-Spans

  2004cited by this paper
• Protection of weaned pigs by vaccination with human adenovirus 5 recombinant viruses expressing the hemagglutinin and the nucleoprotein of H3N2 swine influenza virus.

  2004cited by this paper
• Adenovirus hexon T-cell epitope is recognized by most adults and is restricted by HLA DP4, the most common class II allele

  2004cited by this paper
• Experimental infections of humans with wild-type adenoviruses and with replication-competent adenovirus vectors: replication, safety, and transmission

  2004cited by this paper
• Prevalence of Neutralizing Antibodies to Adenoviral Serotypes 5 and 35 in the Adult Populations of The Gambia, South Africa, and the United States

  2004cited by this paper
• Development of stable liquid formulations for adenovirus-based vaccines.

  2004cited by this paper
• Safety of anthrax vaccine: an expanded review and evaluation of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS)

  2004cited by this paper
• Single Mucosal, but Not Parenteral, Immunization with Recombinant Adenoviral-Based Vaccine Provides Potent Protection from Pulmonary Tuberculosis1

  2004cited by this paper
• Nasal vaccination, Escherichia coli enterotoxin, and Bell's palsy.

  2004cited by this paper
• Structural studies on adenoviruses.

  2003cited by this paper
• Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer.

  2003cited by this paper
• Enhanced Mucosal Immunoglobulin A Response of Intranasal Adenoviral Vector Human Immunodeficiency Virus Vaccine and Localization in the Central Nervous System

  2003cited by this paper
• Adenovirus-transduced lung as a portal for delivering alpha-galactosidase A into systemic circulation for Fabry disease.

  2002cited by this paper
• Development of formulations that enhance physical stability of viral vectors for gene therapy

  2001cited by this paper

• Novel and efficient method for the reconstruction of adenoviruses through isothermal assembly and its potential applications

  2023cites this paper
• Biosafety and Biosecurity in the Era of Biotechnology: The Middle East Region

  2022cites this paper
• Peptide-Based Vaccines for Tuberculosis

  2022cites this paper
• Aerosol delivery, but not intramuscular injection, of adenovirus-vectored tuberculosis vaccine induces respiratory-mucosal immunity in humans

  2022cites this paper
• Recombinant DNA Technology and its Medical Applications

  2021cites this paper
• Prophylactic vaccine delivery systems against epidemic infectious diseases

  2021cites this paper
• Paradoxical modulation of influenza by intranasal administration of non-replicating adenovirus particles

  2020cites this paper
• Translation of Partially-Decayed Messenger RNAs in Yeast

  2019cites this paper
• Adenovirus vector‐based prime‐boost vaccination via heterologous routes induces cervicovaginal CD8+ T cell responses against HPV16 oncoproteins

  2018cites this paper
• Chapter 28 FUTURE PROSPECTS OF VACCINES AND ANTIBODIES IN BIODEFENSE

  2018cites this paper
• Noninvasive vaccination as a casus belli to redeem vaccine value in the face of anti-vaccine movements.

  2017cites this paper
• Role of Recombinant DNA Technology to Improve Life

  2016cites this paper
• Rapid, Efficient, and Modular Generation of Adenoviral Vectors via Isothermal Assembly

  2016cites this paper
• Animal Health: Foot-and-Mouth Disease

  2014cites this paper
• A trail blazed through DNA vaccine, noninvasive vaccine, and innate-adaptive immunity duo

  2014cites this paper
• Intranasal delivery of systemic-acting drugs: small-molecules and biomacromolecules.

  2014cites this paper
• The Yin–Yang arms of vaccines: disease-fighting power versus tissue-destructive inflammation

  2014cites this paper
• Novel Technologies for Vaccine Development

  2014cites this paper
• Adenovirus-Based Vectors for the Development of Prophylactic and Therapeutic Vaccines

  2014cites this paper
• Intramuscular Delivery of Adenovirus Serotype 5 Vector Expressing Humanized Protective Antigen Induces Rapid Protection against Anthrax That May Bypass Intranasally Originated Preexisting Adenovirus Immunity

  2013cites this paper
• Development of chimpanzee adenoviruses as vaccine vectors: challenges and successes emerging from clinical trials

  2013cites this paper
• Perspectives on replication-incompetent nasal influenza virus vaccines

  2012cites this paper
• Recombinant Influenza Vaccines

  2012cites this paper
• Expert Review of Vaccines 10-year anniversary issue

  2011cites this paper